BPL-1357 Against H1N1 Influenza Virus Challenge | MicrobiomeTrials← Back to trialsNCT07215858
BPL-1357 Against H1N1 Influenza Virus Challenge
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-09-15Est. Completion: 2028-03-01
Enrollment target: 129 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
- University of Texas Medical Branch, Galveston, Galveston, Texas, United States
Other microbiome trials you might be interested in
Coronavirus
This first-in-human clinical trial is designed to evaluate the safety and immunogenicity of one administration of OVX033…
Paris, FranceCompleted Jul 8, 2024
Influenza VirusesRespiratory Syncytial Virus (RSV)Severe Acute Respiratory Syndrome Coronavirus 2Human Metapneumovirus (hMPV)Parainfluenza Virus (PIV)AdenovirusRhinovirusCoronavirus
In addition to SarsCov2, the main viral respiratory risks are associated with influenza viruses, respiratory syncytial v…
Multiple LocationsEst. completion Apr 2030